← Eichor
Study identifier: NCT06394934 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients

Condition: Hypertension · Blood Pressure Monitoring, Home · Arteriosclerosis  ·  Sponsor: Korea University Anam Hospital

PhaseN/A
Planned participants4188
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

This observational study investigates the correlation between home blood pressure variability (BPV) and arteriosclerosis, alongside metabolic indicators, in hypertensive patients over a three-year period. The research specifically focuses on the predictive value of home BPV for major adverse cardiovascular events (MACE) including myocardial infarction, stroke, and heart failure hospitalizations. Utilizing a mobile application called Healthscan for daily BP monitoring, the study aims to enhance the understanding of how BPV impacts cardiovascular and metabolic health in a real-world setting.

This description comes directly from the study's public registry record.

Talk to the study team

Ji Hyeon Baek, BSN  ·  82-2-920-5445  ·  jh2bac@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Korea University Anam HospitalSeoul, South KoreaRecruiting
Korea Univeristy Guro HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06394934